Akter, A., & Alam, M. (2022). Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis. Brac University.
Style de citation Chicago (17e éd.)Akter, Anika, et Marzia Alam. Pharmacokinetics, Safety, Efficacy and Immunogenicity of Adalimumab Biosimilar ABP-501in Rheumatoid Arthritis and Plaque Psoriasis. Brac University, 2022.
Style de citation MLA (8e éd.)Akter, Anika, et Marzia Alam. Pharmacokinetics, Safety, Efficacy and Immunogenicity of Adalimumab Biosimilar ABP-501in Rheumatoid Arthritis and Plaque Psoriasis. Brac University, 2022.
Attention : ces citations peuvent ne pas être correctes à 100%.